Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Pulmonary Arterial Dysfunction in Emphysema
NCT02682147Phase 4Active, not recruiting
- Start
- Jul 2017
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sildenafil in emphysema. Started Jul 2017; status: active, not recruiting.
02
Drugs
sildenafil
03
Conditions
emphysema
Beyond the preview
Go deeper on NCT02682147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02682147.